Background
==========

Klinefelter syndrome is the most common sex-linked chromosomal abnormality causing primary hypogonadism, occurring in approximately 1 in 1000 live male births; more than 3000 affected males are born yearly \[[@b1-amjcaserep-17-529]\]. The most common karyotype is 47,XXY, but other variants (including mosaicism of more than 2 X chromosomes) are also observed \[[@b2-amjcaserep-17-529]\]. The major clinical manifestations of Klinefelter syndrome include tall stature, gynecomastia, small testes, a small penis, and infertility. In addition to these clinical characteristics and rare manifestations \[[@b3-amjcaserep-17-529],[@b4-amjcaserep-17-529]\], Klinefelter syndrome patients have an increased risk of several malignancies, especially male breast cancer \[[@b5-amjcaserep-17-529]\] and extragonadal germ cell tumors, primarily localized in the mediastinum \[[@b6-amjcaserep-17-529]\]. However, hematological malignancies, such as leukemia and lymphoma, are not frequent in Klinefelter syndrome patients \[[@b7-amjcaserep-17-529]--[@b10-amjcaserep-17-529]\]. Moreover, data on the incidence of hematological malignancies is limited. In this case report, we describe a patient diagnosed with angioimmunoblastic T-cell lymphoma in whom Klinefelter syndrome was newly detected through physical examination and cytogenetic analyses. To demonstrate the relationship between Klinefelter syndrome and lymphoma, we review previous cases in which lymphoma developed in patients with Klinefelter syndrome.

Case Report
===========

A 61-year-old man initially presented with a palpable neck mass and weight loss in February 2013. He had no relevant family history and had never been married. A physical examination revealed multiple enlarged lymph nodes in the neck, and in axillar and inguinal areas.

The patient was suspected to have a lymphoproliferative disease because multiple homogeneous lymph node enlargements were observed on computed tomography (CT) ([Figure 1A, 1B](#f1-amjcaserep-17-529){ref-type="fig"}) and positron emission tomography (PET)-CT scans ([Figure 1C](#f1-amjcaserep-17-529){ref-type="fig"}). He underwent the excisional biopsy of a right submandibular lymph node showing medium-to-large-sized atypical lymphoid cells infiltration with proliferative high endothelial venules. Immunohistochemical staining showed tumor cells positive for CD3, CD4, PD-1, and negative for CD20. CD21 and clusterin stains showed arborizing follicular dendritic cells. Therefore, these histologic findings and immunohistochemical staining result are compatible with angioimmunoblastic T-cell lymphoma ([Figure 2](#f2-amjcaserep-17-529){ref-type="fig"}).

Because the patient was tall and thin (height: 180.6 cm, body weight: 58.3 kg, and body mass index: 17.87 kg/m^2^) and had a small penis and testes on physical examination, we suspected that he had gonadal dysfunction, similar to that associated with Klinefelter syndrome. As expected, the patient was diagnosed with Klinefelter syndrome (47,XXY/46,XX mosaicism) based on chromosomal analysis of his bone marrow ([Figure 3](#f3-amjcaserep-17-529){ref-type="fig"}). We regarded the body weight loss (14 kg loss during 3 months, 72 kg --\> 58 kg) as B symptom. With respect to IPI (Internal Prognostic Index) score, the patient was in the 'high risk' category of (IPI score 4 point; age \>60 years, serum lactate dehydrogenase concentration above normal, Ann Arbor stage III or IV, number of extranodal disease sites \>1).

After diagnosis, he received 6 cycles of CHOEP (cyclophosphamide, doxorubicin, etoposide, vincristine, and prednisone); he showed an effective response to chemotherapy and achieved a complete response ([Figure 4](#f4-amjcaserep-17-529){ref-type="fig"}). The complete remission state has been maintained for 2 years and he has been receiving regular check-ups every 3 months at an outpatient clinic.

Discussion
==========

There is a strong suspicion that patients with constitutional chromosome abnormalities may be more susceptible to malignancies \[[@b11-amjcaserep-17-529]\]. Klinefelter syndrome patients also have an elevated risk of several cancers, such as male breast cancer and extragonadal germ cell tumors, that are primarily localized in the mediastinum \[[@b5-amjcaserep-17-529],[@b6-amjcaserep-17-529]\]. Altered endogenous hormones, such as elevated estrogen-to-testosterone ratio and elevated gonadotropin level, have been the primary focus for explaining the observed increase in male breast cancer and extragonadal germ cell tumors among Klinefelter syndrome patients \[[@b11-amjcaserep-17-529],[@b12-amjcaserep-17-529]\], but hematological malignancies are not frequent in Klinefelter syndrome. The current case study joins a handful of previously documented cases of lymphoproliferative disease in patients with Klinefelter syndrome ([Table 1](#t1-amjcaserep-17-529){ref-type="table"}), indicating that Klinefelter syndrome may, in fact, be associated with an increased incidence of and mortality from lymphoproliferative disease \[[@b11-amjcaserep-17-529]\]. Swerdlow et al. suggested that this relationship is due to the over-activation of an oncogene on the X chromosome that evokes escape of X inactivation, and that the risk of lymphoma was especially high in males who have multiple X chromosomes \[[@b13-amjcaserep-17-529]\]. There are no available data on whether immunologic problems develop more frequently in patients with Klinefelter syndrome than in those with normal karyotype; however, several reports suggested that the prevalence of autoimmune diseases, including systemic lupus erythematosus, may be elevated in males with Klinefelter syndrome \[[@b14-amjcaserep-17-529]--[@b16-amjcaserep-17-529]\].

Klinefelter syndrome is a rare disorder. In addition, Klinefelter syndrome is severely underdiagnosed or diagnosed late in life. Roughly 25% of the expected number of cases are diagnosed, and the mean age at diagnosis is in the mid-30s. The reason for the underdiagnoses and late diagnoses is unknown, but the relatively mild phenotype is a tempting explanation \[[@b17-amjcaserep-17-529]\]. Our patient also had mild phenotype (47,XXY/46,XX) and late diagnosis compared to the mean age. Because of its rarity and low diagnosis rate, there are few published studies or case reports about its association with lymphoma. Including our patient, we identified a total of 10 reported cases with malignant lymphoma in association with Klinefelter syndrome. Although the consensus is that associations between Klinefelter syndrome and hematological conditions are purely coincidental, the uncertainty can only be resolved through the collection of more data.

Conclusions
===========

There is strong evidence that patients with constitutional chromosome abnormalities may be more susceptible to malignancy. Klinefelter syndrome patients have elevated risk of several cancers, but hematological malignancy has not been documented in Klinefelter syndrome patients until now. The development of angioimmunoblastic T-cell lymphoma in patients with Klinefelter syndrome is rare. Although evidence suggests that associations between Klinefelter syndrome and hematological conditions are purely coincidental, the uncertainty can only be resolved by more data.

![(**A, B**) An initial contrast-enhanced computed tomography (CT) scan revealed multiple homogeneous lymph node enlargements in the retrotracheal, paratracheal, and aortopulmonary window, and the retrocaval, aortocaval, and paraaortic lymph nodes (arrow) without solid-organ involvement, which are suggestive of lymphoma. (**C**) Initial 18F-fluorodeoxyglucose positron emission tomography/CT showed multiple hypermetabolic lymph nodes in the bilateral cervical, axillary, mediastinal, hilar, interlobar, retroperitoneal, iliac, and inguinal areas, which were suggestive of lymphoma. Additionally, the oral cavity and major salivary glands had diffusely increased metabolism.](amjcaserep-17-529-g001){#f1-amjcaserep-17-529}

![(**A**) Histopathologic findings revealed intermediate-sized neoplastic T-cells with clear cytoplasm and proliferation of high endothelial venules (hematoxylin and eosin ×100). (**B**) Immunohistochemical staining for CD21 revealed arborizing follicular dendritic cells in a low-power view (CD21 immunostain ×40). (**C**) Tumor cells are positive for CD3 (×200). (**D**) Tumor cells are positive for CD4 (×200).](amjcaserep-17-529-g002){#f2-amjcaserep-17-529}

![Cytogenetic analysis of a bone marrow specimen showed 46,XX(A)/47,XXY(B) mosaicism (arrow indicates the additional X chromosome), which indicates a diagnosis of Klinefelter syndrome.](amjcaserep-17-529-g003){#f3-amjcaserep-17-529}

![(**A, B**) After 6 cycles of CHOEP chemotherapy, the multiple enlarged lymph nodes disappeared or decreased on a post-chemotherapy contrast-enhanced computed tomography (CT) scan. (**C**) Multiple lymphoma lesions disappeared or decreased on post-chemotherapy 18F-fluorodeoxyglucose positron emission tomography (FDG-PET)/CT. However, focal mildly hypermetabolic lymph nodes remained in the bilateral mediastinal, hilar, and interlobar areas and were assessed as reactive nodes rather than residual lymphoma lesions. The 18F-FDG uptakes of the oral cavity and major salivary glands were normal when compared with the initial 18F-FDG PET/CT.](amjcaserep-17-529-g004){#f4-amjcaserep-17-529}

###### 

Case reports of lymphoma associated with Klinefelter syndrome.

  **Year**   **Age**   **Histology**                        **Karyotype**          **Chemotherapy**                                                                          **Reference no.**
  ---------- --------- ------------------------------------ ---------------------- ----------------------------------------------------------------------------------------- ------------------------------
  1965       53 y      Reticulum cell sarcoma               48,XXXY/47,XXY/46,XY                                                                                             \[[@b18-amjcaserep-17-529]\]
  1974       46 y      Low-grade lymphoma                   47,XXY/46,XY                                                                                                     \[[@b19-amjcaserep-17-529]\]
  1986       47 y      High-grade B-cell lymphoma           47,XXY/46,XY                                                                                                     \[[@b20-amjcaserep-17-529]\]
  1987       10 y      Malignant histiocytosis              47,XXY                                                                                                           \[[@b21-amjcaserep-17-529]\]
  1990       33 y      Immunoblastic B-cell lymphoma        47,XXY                                                                                                           \[[@b22-amjcaserep-17-529]\]
  1994       40 mo     B-lymphoblastic lymphoma             47,XXY                                                                                                           \[[@b23-amjcaserep-17-529]\]
  1997       81 y      Low-grade B-cell lymphoma            47,XXY/46,XY           None                                                                                      \[[@b14-amjcaserep-17-529]\]
  2002       29 y      Anaplastic large-cell lymphoma       47,XXY                 Cyclophosphamide, Adriamycin, Oncovin, prednisone                                         \[[@b24-amjcaserep-17-529]\]
  2002       31 y      Anaplastic Ki-1 lymphoma             47,XXY                 High-dose cyclophosphamide (followed by matched allogeneic bone marrow transplantation)   \[[@b24-amjcaserep-17-529]\]
  Current    64 y      Angioimmunoblastic T-cell lymphoma   47,XXY/46,XX           Cyclophosphamide, doxorubicin, etoposide, vincristine, and prednisone                     
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